Literature DB >> 32453188

Demographics of Patients Receiving Electroconvulsive Therapy Based on State-Mandated Reporting Data.

James Luccarelli1, Michael E Henry, Thomas H McCoy.   

Abstract

OBJECTIVES: Electroconvulsive therapy (ECT) is an effective treatment of depression and other psychiatric conditions. There are few comprehensive data on how many patients receive ECT in the United States or about the demographics of ECT recipients. This study characterizes the demographics of those receiving ECT and how these demographics may have changed with time.
METHODS: Freedom of information requests for all data from record keeping inception to January 2019 were sent to the Department of Health or equivalent agency of states that mandate reporting of ECT. Information on demographics and the number of treating facilities was extracted.
RESULTS: Data on 62,602 patients receiving treatment in 3 states (California, Illinois, Vermont) were obtained. Overall, 62.3% were women. Fewer than 1% of patients treated were younger than 18 years, whereas 30.3% were 65 years or older. White patients received a disproportionate proportion of treatments, with all other races underrepresented. The total number of facilities offering ECT in the 3 states declined over the study period.
CONCLUSIONS: Recipients of ECT are more likely to be female, more likely to be elderly, and more likely to be white than the average person in their state.

Entities:  

Mesh:

Year:  2020        PMID: 32453188      PMCID: PMC7677170          DOI: 10.1097/YCT.0000000000000692

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.692


  32 in total

1.  Use of ECT in California, revisited: 1984-1994.

Authors:  B A Kramer
Journal:  J ECT       Date:  1999-12       Impact factor: 3.635

2.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

Review 3.  Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis.

Authors:  Bram Dierckx; Willemijn T Heijnen; Walter W van den Broek; Tom K Birkenhäger
Journal:  Bipolar Disord       Date:  2012-03       Impact factor: 6.744

4.  Electroconvulsive Therapy (ECT) and Race: A Report of ECT Use and Sociodemographic Trends in Texas.

Authors:  Julie Williams; Lawrence Chiu; Robin Livingston
Journal:  J ECT       Date:  2017-06       Impact factor: 3.635

5.  Aging and Family Life: A Decade Review.

Authors:  Merril Silverstein; Roseann Giarrusso
Journal:  J Marriage Fam       Date:  2010-10

6.  The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients.

Authors:  Lisa A Cooper; Junius J Gonzales; Joseph J Gallo; Kathryn M Rost; Lisa S Meredith; Lisa V Rubenstein; Nae-Yuh Wang; Daniel E Ford
Journal:  Med Care       Date:  2003-04       Impact factor: 2.983

Review 7.  Practice parameter for use of electroconvulsive therapy with adolescents.

Authors:  Neera Ghaziuddin; Stanley P Kutcher; Penelope Knapp; William Bernet; Valerie Arnold; Joseph Beitchman; R Scott Benson; Oscar Bukstein; Joan Kinlan; Jon McClellan; David Rue; Jon A Shaw; Saundra Stock; Kristin Kroeger Ptakowski
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-12       Impact factor: 8.829

8.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

9.  A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders.

Authors:  Carsten Bøcker Pedersen; Ole Mors; Aksel Bertelsen; Berit Lindum Waltoft; Esben Agerbo; John J McGrath; Preben Bo Mortensen; William W Eaton
Journal:  JAMA Psychiatry       Date:  2014-05       Impact factor: 21.596

10.  Use of ECT in the United States in 1975, 1980, and 1986.

Authors:  J W Thompson; R D Weiner; C P Myers
Journal:  Am J Psychiatry       Date:  1994-11       Impact factor: 18.112

View more
  7 in total

1.  Individual response to electroconvulsive therapy is not correlated between multiple treatment courses.

Authors:  Kamber L Hart; Michael E Henry; Thomas H McCoy; Stephen J Seiner; James Luccarelli
Journal:  J Affect Disord       Date:  2021-11-04       Impact factor: 4.839

2.  Real-world evidence of age-independent electroconvulsive therapy efficacy: A retrospective cohort study.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  Acta Psychiatr Scand       Date:  2021-10-25       Impact factor: 6.392

3.  Rapid Resolution of Prolonged Benzodiazepine-Refractory Catatonia With Electroconvulsive Therapy in an Adolescent Patient: A Case Report.

Authors:  James Luccarelli; Carlos Fernandez-Robles; Bryce Wininger; Jessica E Becker; Eric P Hazen; Michael E Henry
Journal:  J ECT       Date:  2022-04-05       Impact factor: 3.692

4.  The Effects of Baseline Impaired Global Cognitive Function on the Efficacy and Cognitive Effects of Electroconvulsive Therapy in Geriatric Patients: A Retrospective Cohort Study.

Authors:  James Luccarelli; Brent P Forester; Mary Dooley; Regan E Patrick; David G Harper; Stephen J Seiner; Georgios Petrides; Martina Mueller; Michael E Henry
Journal:  Am J Geriatr Psychiatry       Date:  2021-12-17       Impact factor: 7.996

5.  The Efficacy and Cognitive Effects of Acute Course Electroconvulsive Therapy Are Equal in Adolescents, Transitional Age Youth, and Young Adults.

Authors:  James Luccarelli; Thomas H McCoy; Mai Uchida; Allison Green; Stephen J Seiner; Michael E Henry
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-10-06       Impact factor: 3.031

6.  The Incidence of Catatonia Diagnosis Among Pediatric Patients Discharged From General Hospitals in the United States: A Kids' Inpatient Database Study.

Authors:  James Luccarelli; Mark Kalinich; Carlos Fernandez-Robles; Gregory Fricchione; Scott R Beach
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 5.435

7.  Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.

Authors:  Zafiris J Daskalakis; Carol Tamminga; Alanah Throop; Lucy Palmer; Julia Dimitrova; Faranak Farzan; Kevin E Thorpe; Shawn M McClintock; Daniel M Blumberger
Journal:  Trials       Date:  2021-11-08       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.